Lycopene supplementation in rheumatic diseases: a comprehensive review

Abstract

Antioxidant and anti-inflammatory compound whose biological properties have been linked to modulation of oxidative stress, cytokine signaling, and bone metabolism. Given the central role of oxidative and inflammatory mechanisms in rheumatic diseases, lycopene has emerged as a potential nutraceutical adjunct. This narrative review summarizes current evidence regarding lycopene supplementation and its effects on rheumatic and musculoskeletal disorders, integrating clinical, preclinical, and mechanistic data into a single comprehensive synthesis. A literature search was conducted in PubMed, SciELO, and LILACS up to July 2024, focusing on studies evaluating lycopene in rheumatic or musculoskeletal contexts. Three human studies met the inclusion criteria, all conducted in postmenopausal women, and demonstrated beneficial effects on bone metabolism and oxidative stress markers without adverse effects. Additional experimental evidence supports lycopene’s antioxidant, anti-inflammatory, and bone-protective actions, reinforcing its potential biological relevance in rheumatology. Overall, the available evidence suggests that lycopene may represent a promising, safe, and accessible adjunct for oxidative stress modulation and bone preservation, particularly in osteoporosis. However, the magnitude and durability of these effects remain to be clarified in larger, well-designed randomized trials, especially in inflammatory rheumatic diseases.

Keywords

rheumatic diseases / osteoporosis / lycopene / carotenoid / antioxidant / inflammation

References

[1] Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.

[2] Grabowska M, Wawrzyniak D, Rolle K, Chomczyński P, Oziewicz S, Jurga S, et al. Let food be your medicine: nutraceutical properties of lycopene. Food Funct. 2019; 10: 3090-102.

[3] Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 1995; 9: 1551-8.

[4] Chen F, Du M, Blumberg JB, Ho Chui KK, Ruan M, Rogers G, et al. Association Among Dietary Supplement Use, Nutrient Intake, and Mortality Among U.S. Adults: A Cohort Study. Ann Intern Med. 2019; 170: 604-13.

[5] Russo C, Ferro Y, Maurotti S, Salvati MA, Mazza E, Pujia R, et al. Lycopene and bone: an in vitro investigation and a pilot prospective clinical study. J Transl Med. 2020; 18: 43.

[6] Meeta M, Sharma S, Unni J, Khandelwal S, Choranur A, Malik S. Cardiovascular and Osteoporosis Protection at Menopause with Lycopene: A Placebo-Controlled Double-Blind Randomized Clinical Trial. J Midlife Health. 2022; 13: 50-6.

[7] Mackinnon ES, Rao AV, Josse RG, Rao LG. Supplementation with the antioxidant lycopene significantly decreases oxidative stress parameters and the bone resorption marker N-telopeptide of type I collagen in postmenopausal women. Osteoporos Int. 2011; 22: 1091-101.

[8] Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989; 274: 532-8.

[9] Palozza P, Catalano A, Simone R, Cittadini A. Lycopene as a guardian of redox signalling. Acta Biochim Pol. 2012; 59: 21-5.

[10] Park B, Lim JW, Kim H. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells. Nutr Res. 2019; 70: 70-81.

[11] Imran M, Ghorat F, Ul-Haq I, Ur-Rehman H, Aslam F, Heydari M, et al. Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders. Antioxidants (Basel). 2020; 9: 706.

[12] Sahni S, Hannan MT, Blumberg J, Cupples LA, Kiel DP, Tucker KL. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res. 2009; 24: 1086-94.

[13] Iimura Y, Agata U, Takeda S, Kobayashi Y, Yoshida S, Ezawa I, et al. Lycopene intake facilitates the increase of bone mineral density in growing female rats. J Nutr Sci Vitaminol (Tokyo). 2014; 60: 101-7.

[14] Cervellati C, Bergamini CM. Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clin Chem Lab Med. 2016; 54: 739-53.

[15] Izzo C, Vitillo P, Di Pietro P, Visco V, Strianese A, Virtuoso N, et al. The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases. Life (Basel). 2021; 11: 60.

[16] Hofbauer LC, Kühne CA, Viereck V. The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet Neuronal Interact. 2004; 4: 268-75.

[17] Sluijs I, Beulens JW, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J Nutr. 2009; 139: 987-92.

[18] Li C, Liang Y, Lu Q, Lin Y, Wen S, Luo X, et al. Protective effect of serum carotenoids on mortality among metabolic syndrome patients: attenuated by lipid-lowering drugs. Nutr J. 2025; 24: 27.

[19] Hajizadeh-Sharafabad F, Zahabi ES, Malekahmadi M, Zarrin R, Alizadeh M. Carotenoids supplementation and inflammation: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2022; 62: 8161-77.

[20] Cordero MD, de Miguel M, Carmona-López I, Bonal P, Campa F, Moreno-Fernández AM. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett. 2010; 31: 169-73.

[21] Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG. Oxidative stress in autoimmune rheumatic diseases. Free Radic Biol Med. 2018; 125: 3-14.

[22] Tan C, Xue J, Lou X, Abbas S, Guan Y, Feng B, et al. Liposomes as delivery systems for carotenoids: comparative studies of loading ability, storage stability and in vitro release. Food Funct. 2014; 5: 1232-40.